A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Clinical trial NCT05417932 · RECRUITING
Trial details
- NCT number
- NCT05417932
- Sponsor
- SCG Cell Therapy Pte. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2025-09-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.